MeSH tree: A15.382.680
Most cancer deaths are not caused by the original tumor, but by metastases, which form when cancer cells leave the original tumor and spread to other organs. To do so, cancer cells must loosen their attachment to other cancer ...
4 hours ago
0
6
A new study from Mayo Clinic suggests checkpoint immunotherapy may reshape the immune environment within lymph nodes after melanoma has spread to them. Researchers found that treatment reorganized several types of immune ...
Oct 30, 2026
0
59
Sustained low-level inflammation is a hallmark of the aging process. The accumulating damage persistently activates the innate immune system—the body's first line of defense—leading to what is known as inflammaging, functional ...
Oct 28, 2026
0
1247
One person dies every 50 seconds in the U.S. from cancer, and an estimated 39% of people in the country will develop cancer during their lifetime. Survival rates have improved in recent decades from innovations and combinations ...
Oct 28, 2026
0
7
Immune cells that normally protect the body from infection can also drive the progression of some early breast cancers, McGill University researchers have found.
Oct 20, 2026
0
10
A team led by Harvard Medical School researchers at Beth Israel Deaconess Medical Center and Dana-Farber Cancer Institute has developed a faster way to identify and engineer cancer-fighting therapies.
Oct 15, 2026
0
10
The COVID-19 pandemic showed the challenges of protecting populations when a new respiratory virus emerges. Although vaccines were developed at unprecedented speed, there was still a period when vaccines were not yet available, ...
Oct 9, 2026
0
9
Our bodies contain immune cells called macrophages. Normally, these cells attack and suppress bacteria and cancer cells. However, when macrophages infiltrate tumors, they can become tumor-associated macrophages (TAMs) and ...
Oct 8, 2026
0
61
A common bacterium found in the mouth and airways may help the lungs better defend themselves against pneumonia, according to new research from the University of Colorado Anschutz.
Oct 7, 2026
0
12
For the first time in a human trial, a class of drugs known as sodium-glucose cotransporter-2 (SGLT2) inhibitors, already known for their weight-loss and glucose-lowering benefits, has also been shown to reduce inflammatory ...
Oct 6, 2026
0
23
